Diabetic nephropathy: SGLT2 inhibitors might halt progression of diabetic nephropathy
- PMID: 27425155
- DOI: 10.1038/nrneph.2016.109
Diabetic nephropathy: SGLT2 inhibitors might halt progression of diabetic nephropathy
Comment on
-
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes.N Engl J Med. 2016 Jul 28;375(4):323-34. doi: 10.1056/NEJMoa1515920. Epub 2016 Jun 14. N Engl J Med. 2016. PMID: 27299675 Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
